Masahiro Chiba
6PUBLICATIONS
15CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Nov 10, 2025
Correction: Genome-wide CRISPR screen identifies MAD2L1BP and ANAPC15 as targets for brentuximab vedotin sensitivity in CD30+ peripheral T-cell lymphoma.Keito Suto, Norio Takei, Keito Yokoyama
|Oct 21, 2024
Genome-wide CRISPR screen identifies MAD2L1BP and ANAPC15 as targets for brentuximab vedotin sensitivity in CD30+ peripheral T-cell lymphoma.Keito Suto, Norio Takei, Keito Yokoyama
|Dec 24, 2023
Whole-genome CRISPR screening identifies molecular mechanisms of PD-L1 expression in adult T-cell leukemia/lymphoma.Masahiro Chiba, Joji Shimono, Keito Suto
|Dec 01, 2022
Analysis and therapeutic targeting of the EP300 and CREBBP acetyltransferases in anaplastic large cell lymphoma and Hodgkin lymphoma.Wei Wei, Zhihui Song, Masahiro Chiba
|Aug 03, 2022
Genome-wide CRISPR screens identify CD48 defining susceptibility to NK cytotoxicity in peripheral T-cell lymphomas.Masahiro Chiba, Joji Shimono, Takashi Ishio
Pageof 1
Frequent Collaborators
6 joint publications
Masao Nakagawa
5 joint publications
Takanori Teshima
5 joint publications
Yibin Yang
4 joint publications
Keito Suto
3 joint publications
Hiroo Hasegawa
2 joint publications
Joji Shimono
1 joint publications
Norio Takei
1 joint publications
Reiki Ogasawara
1 joint publications
Takahide Ara
1 joint publications
Koh Izumiyama